Skip to main content
Payal Kohli on Muck Rack

Payal Kohli

  • Health Expert, KUSA-TV (Denver, CO)
  • Medical Expert, Freelance
  • Associate Adjunct Professor in Cardiology Division, Department of Medicine, Duke University Hospital
  • Adjunct Associate Professor in Cardiology Division, Johns Hopkins University
Denver
As seen in: KUSA-TV (Denver, CO), Wiley Online Library, Medical News Today, NDTV, Medscape, MedPage Today, Healio Cardiology, HCP Live, South Florida Reporter, Doc Wire News, Doximity's Op-Med
Cardiologist, @9News, Tegna Medical Expert, Writer, @harvardmed, @BrighamWomens, @cherrycreekheart, host of #HeARTofMedicine, 5280 Top Doc, Cardiologist of Year
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Payal

Contact Payal, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Addressing Fenofibrates’ Lack of Cardiovascular Benefit, With Payal Kohli, MD, FACC

|
By Payal Kohli
| consultantlive.com
Despite increasing evidence indicating their ineffectiveness and a recent decision by the US Food and Drug Administration (FDA) to update their labeling information to reflect their lack of cardiovascular benefit, fenofibrates are still actively being prescribed to reduce cardiovascular risk, both alone and in combination with statins.1,2 On October 14, 2025, in response to a Citizen Petition from the organization HealthyWomen, the FDA changed the labels for fenofibrates, highlighting the...
Open in Who Shared View Duplicates (2) Issue with article?

AHA 2025: Insights on Icosapent Ethyl and Cardiovascular Care

|
By Payal Kohli, Deepak L. Bhatt
| radcliffecvrm.com
Overview Filmed onsite at the AHA 2025 congress, leading specialists Dr Payal Kohli and Dr Deepak Bhatt explore the evolving landscape of triglyceride-lowering therapy in cardiovascular disease.
Open in Who Shared Issue with article?

Patient Case No. 2

|
By Manesh R. Patel, Payal Kohli, John Flack Verified, C. Michael Gibson
| consultantlive.com
Advancing Hypertension Management: Unmet Needs, Endothelial Dysfunction, and CKD Therapies - Episode 11 Published on: , , , Panelists discuss how chronic kidney disease (CKD) and uncontrolled hypertension create a damaging cycle, in which hypertension accelerates kidney damage while declining kidney function makes blood pressure harder to control. Patient No. 2 has stage 3 CKD and uncontrolled hypertension.
Open in Who Shared Issue with article?
See all 68 licensed articles (110 Total)